Literature DB >> 28676900

Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin, and TNF-α in knee osteoarthritis patients.

Sicong Min1,2, Chao Wang1,2, Wanli Lu1,2, Zhihong Xu1,2, Dongquan Shi1,2, Dongyang Chen1,2, Huajian Teng3,4, Qing Jiang5,6.   

Abstract

Knee osteoarthritis (KOA) is a common degenerative joint disease causing pain, stiffness, reduced motion, swelling, crepitus, and disability. Several inflammatory markers and cartilage degradation products can be used as biomarkers in OA. The key factors of bone metabolism in normal joint bone, dickkopf-1 (DKK1) and osteoprotegerin (OPG), interact with Wnt signaling pathway, balancing between bone absorption and bone reconstruction. TNF-α is a key inducer of DKK-1, which belongs to the family of proteins involved in joint remodeling. The present study compared the serum levels of DKK1, TNF-α, and OPG in patients with KOA and healthy controls to analyze the interrelationship and the severity of joint destruction. One hundred forty-eight patients with KOA and 101 healthy controls were enrolled in this study. Anteroposterior knee radiographs determined the severity of the disease in the affected knee. The radiographic grading of KOA was performed by the Kellgren-Lawrence criteria. Serum levels of DKK-1, TNF-α, and OPG were estimated using the multiplex particle-based flow cytometry. Higher serum levels of OPG and TNF-α were observed in KOA than the controls; KOA patients showed a lower serum level of DKK-1, whereas the serum levels of DKK1 correlated with the progression of KOA. The serum levels of TNF-α, OPG, and DKK-1 correlated with incident KOA. In the ROC curve analysis, DKK1 levels showed 78.6% sensitivity and 40% specificity, TNF-α levels showed 74.1% sensitivity and 76.0% specificity, and OPG showed 88.1% sensitivity and 81% specificity in predicting severe KOA. In the univariate and multivariate analyses, TNF-α and OPG emerged as independent predictors of severe KOA. This study, for the first time, combined TNF-α, DKK1, and OPG as valuable biological markers in predicting the severity of KOA radiographically in the clinic. This study also supported the inflammation-induced DKK1 and OPG in OA pathogenesis.

Entities:  

Keywords:  DKK1; Knee osteoarthritis; OPG; Serum; TNF-α

Mesh:

Substances:

Year:  2017        PMID: 28676900     DOI: 10.1007/s10067-017-3690-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  41 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

3.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

4.  Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis.

Authors:  B Y Chan; E S Fuller; A K Russell; S M Smith; M M Smith; M T Jackson; M A Cake; R A Read; J F Bateman; P N Sambrook; C B Little
Journal:  Osteoarthritis Cartilage       Date:  2011-05-12       Impact factor: 6.576

5.  The current and future status of biomarkers in osteoarthritis.

Authors:  David T Felson
Journal:  J Rheumatol       Date:  2014-05       Impact factor: 4.666

Review 6.  Regulation of bone mass by Wnt signaling.

Authors:  Venkatesh Krishnan; Henry U Bryant; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 7.  New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Carmen Ruiz Velasco; Marc Padrines; Johanne Martel-Pelletier
Journal:  Keio J Med       Date:  2009-03

8.  Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study.

Authors:  Sittisak Honsawek; Maneerat Chayanupatkul; Aree Tanavalee; Manoon Sakdinakiattikoon; Benjamad Deepaisarnsakul; Pongsak Yuktanandana; Srihatach Ngarmukos
Journal:  Int Orthop       Date:  2009-03-20       Impact factor: 3.075

9.  Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Elena E Solomou; Anastasia Tsanaktsi; Konstadina Bounia; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Arthritis Rheum       Date:  2010-01

10.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  20 in total

1.  Preemptive meloxicam achieves a better effect on postoperative pain control and similar tolerance compared with postoperative meloxicam in patients receiving arthroscopic knee surgery.

Authors:  Yanxin Yuan; Dan Cui; Yunhong Zhang
Journal:  Inflammopharmacology       Date:  2019-06-28       Impact factor: 4.473

Review 2.  WNT Signalling in Osteoarthritis and Its Pharmacological Targeting.

Authors:  Anna De Palma; Giovanna Nalesso
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Transient neonatal shoulder paralysis causes early osteoarthritis in a mouse model.

Authors:  Lynn Ann Forrester; Fei Fang; Timothy Jacobsen; Yizhong Hu; Iden Kurtaliaj; Benjamin D Roye; X Edward Guo; Nadeen O Chahine; Stavros Thomopoulos
Journal:  J Orthop Res       Date:  2021-12-03       Impact factor: 3.102

Review 4.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

5.  Phonopheresis Associated with Nanoparticle Gel from Phyllanthus amarus Relieves Pain by Reducing Oxidative Stress and Proinflammatory Markers in Adults with Knee Osteoarthritis.

Authors:  Pinkaew Decha; Kiattisin Kanokwan; Tocharus Jiraporn; Jumnongprakhon Pichaya; Awoot Pisittawoot
Journal:  Chin J Integr Med       Date:  2019-10-24       Impact factor: 1.978

6.  Chondroprotective Effect of Wufu Decoction on Tumor Necrosis Factor-α-Induced Chondrocytes via the Extracellular Signal Regulated Kinase 1/2 Signaling Pathway.

Authors:  Zheng-Cong Ye; Can-Feng Wang; Lei Han; Guo-Ping Cao; Qin-Rong Shen
Journal:  Orthop Surg       Date:  2020-07-23       Impact factor: 2.071

7.  Advanced glycosylated end products restrain the osteogenic differentiation of the periodontal ligament stem cell.

Authors:  Zhu-Ling Guo; Shan-Ling Gan; Chun-Yi Cao; Rao Fu; Sheng-Ping Cao; Chen Xie; Jing-Wei Chen; Alex Gibson; Xu Zheng; Nai-Chia Teng
Journal:  J Dent Sci       Date:  2019-04-16       Impact factor: 2.080

8.  Inflammation-Related Patterns in the Clinical Staging and Severity Assessment of Chronic Kidney Disease.

Authors:  Simona Mihai; Elena Codrici; Ionela D Popescu; Ana-Maria Enciu; Elena Rusu; Diana Zilisteanu; Laura G Necula; Gabriela Anton; Cristiana Tanase
Journal:  Dis Markers       Date:  2019-10-07       Impact factor: 3.434

9.  Efficacy of autologous bone marrow mesenchymal stem cells in the treatment of knee osteoarthritis and their effects on the expression of serum TNF-α and IL-6.

Authors:  Jianrui Li; Qin Shao; Xiaobo Zhu; Guixini Sun
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

Review 10.  BONE MARKERS IN ARTHROPATHIES.

Authors:  Roxana Răduț; Alexandra M Crăciun; Ciprian N Silaghi
Journal:  Acta Clin Croat       Date:  2019-12       Impact factor: 0.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.